Yingfeng Lu

3.8k total citations
42 papers, 1.2k citations indexed

About

Yingfeng Lu is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Yingfeng Lu has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 14 papers in Molecular Biology and 13 papers in Infectious Diseases. Recurrent topics in Yingfeng Lu's work include COVID-19 Clinical Research Studies (8 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Yingfeng Lu is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Yingfeng Lu collaborates with scholars based in China, United States and Canada. Yingfeng Lu's co-authors include Lanjuan Li, Jifang Sheng, Jiangshan Lian, Yanqing Wu, Jian Wang, Jianhua Hu, Ciliang Jin, Jueqing Gu, Chanyuan Ye and Huan Cai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Analytical Chemistry.

In The Last Decade

Yingfeng Lu

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingfeng Lu China 16 392 369 228 155 127 42 1.2k
Nidhi Kapoor United States 17 497 1.3× 307 0.8× 229 1.0× 117 0.8× 271 2.1× 64 1.5k
Masataka Nishiga Japan 14 418 1.1× 562 1.5× 330 1.4× 32 0.2× 152 1.2× 27 1.6k
Shijie Wang China 20 507 1.3× 163 0.4× 162 0.7× 70 0.5× 127 1.0× 104 1.4k
Monika Litviňuková Germany 7 281 0.7× 1.1k 3.0× 498 2.2× 106 0.7× 166 1.3× 7 1.9k
Quynh Nguyen United States 18 638 1.6× 938 2.5× 444 1.9× 70 0.5× 140 1.1× 56 2.1k
Wenbin Tan United States 21 326 0.8× 296 0.8× 169 0.7× 29 0.2× 147 1.2× 48 1.3k
Jurgen Sota Italy 20 424 1.1× 66 0.2× 65 0.3× 52 0.3× 94 0.7× 67 1.7k
Ying Meng China 24 721 1.8× 184 0.5× 67 0.3× 44 0.3× 357 2.8× 76 1.7k
Xiaoming Li China 17 210 0.5× 289 0.8× 110 0.5× 21 0.1× 282 2.2× 55 1.3k

Countries citing papers authored by Yingfeng Lu

Since Specialization
Citations

This map shows the geographic impact of Yingfeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingfeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingfeng Lu more than expected).

Fields of papers citing papers by Yingfeng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingfeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingfeng Lu. The network helps show where Yingfeng Lu may publish in the future.

Co-authorship network of co-authors of Yingfeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingfeng Lu. A scholar is included among the top collaborators of Yingfeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingfeng Lu. Yingfeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lu, Yingfeng, Qinghui Chen, Youyi Zhang, et al.. (2024). Impact of COVID‐19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children. Influenza and Other Respiratory Viruses. 18(4). e13291–e13291. 5 indexed citations
3.
Chen, Deying, Yingfeng Lu, Jiangshan Lian, et al.. (2024). Plasma metabolome analysis for predicting antiviral treatment efficacy in chronic hepatitis B: diagnostic biomarkers and therapeutic insights. Frontiers in Immunology. 15. 1414476–1414476.
4.
Lu, Yingfeng, et al.. (2024). Atom-ProteinQA: Atom-level protein model quality assessment through fine-grained joint learning. Computer Methods and Programs in Biomedicine. 249. 108078–108078. 1 indexed citations
5.
Yao, Yan, et al.. (2024). FGF21 inhibits ferroptosis caused by mitochondrial damage to promote the repair of peripheral nerve injury. Frontiers in Pharmacology. 15. 1358646–1358646. 8 indexed citations
6.
Zhao, Na, Yiwen Cheng, Yiran Xu, et al.. (2023). Exploring the gut mycobiome: differential composition and clinical associations in hypertension, chronic kidney disease, and their comorbidity. Frontiers in Immunology. 14. 1317809–1317809. 7 indexed citations
7.
8.
Ye, Chanyuan, Yan Lv, Lisha Yang, et al.. (2022). Inactivated vaccines prevent severe COVID‐19 in patients infected with the Delta variant: A comparative study of the Delta and Alpha variants from China. Journal of Medical Virology. 94(8). 3613–3624. 3 indexed citations
9.
10.
Lv, Longxian, Huiyong Jiang, Xiaoxiao Chen, et al.. (2021). The Salivary Microbiota of Patients With Primary Biliary Cholangitis Is Distinctive and Pathogenic. Frontiers in Immunology. 12. 713647–713647. 14 indexed citations
11.
Cai, Huan, Lisha Yang, Yingfeng Lu, et al.. (2021). High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study. BMC Infectious Diseases. 21(1). 147–147. 9 indexed citations
12.
Lu, Yingfeng, Yan Ren, Jiangshan Lian, et al.. (2021). Dynamic metabolic profiles for HBeAg seroconversion in chronic hepatitis B (CHB) patients by gas chromatography-mass spectrometry (GC-MS). Journal of Pharmaceutical and Biomedical Analysis. 206. 114349–114349. 1 indexed citations
13.
Shi, Ding, Yan Ren, Longxian Lv, et al.. (2021). The serum metabolome of COVID-19 patients is distinctive and predictive. Metabolism. 118. 154739–154739. 87 indexed citations
14.
Lu, Yingfeng, et al.. (2021). Preliminary Assessment of Chinese Strategy in Controlling Reemergent Local Outbreak of COVID-19. Frontiers in Public Health. 9. 650672–650672. 7 indexed citations
15.
Lu, Yingfeng, Rui Li, Jun‐yi Zhu, et al.. (2018). Fibroblast growth factor 21 facilitates peripheral nerve regeneration through suppressing oxidative damage and autophagic cell death. Journal of Cellular and Molecular Medicine. 23(1). 497–511. 53 indexed citations
16.
Lian, Jiangshan, Xiaolin Zhang, Yingfeng Lu, et al.. (2018). Switching Lamivudine with Adefovir Dipivoxil Combination Therapy to Entecavir Monotherapy Provides Better Viral Suppression and Kidney Safety. International Journal of Medical Sciences. 16(1). 17–22. 1 indexed citations
17.
Li, Rui, Yiyang Li, Yanqing Wu, et al.. (2018). Heparin-Poloxamer Thermosensitive Hydrogel Loaded with bFGF and NGF Enhances Peripheral Nerve Regeneration in Diabetic Rats. Biomaterials. 168. 24–37. 200 indexed citations
18.
Zhang, Yimin, Wei Yu, Ning Zhou, et al.. (2015). High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid. Hepatobiliary & pancreatic diseases international. 14(3). 287–292. 19 indexed citations
19.
Zheng, Yunliang, Jian Chen, & Yingfeng Lu. (2015). Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials. Drug Design Development and Therapy. 9. 4751–4751. 27 indexed citations
20.
Gu, Yu, Tianxiang Chen, Xin Sun, et al.. (2015). Perioperative dynamics and significance of amino acid profiles in patients with cancer. Journal of Translational Medicine. 13(1). 35–35. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nidhi Kapoor Breakdown of academic impact, for papers by Masataka Nishiga Breakdown of academic impact, for papers by Shijie Wang Breakdown of academic impact, for papers by Monika Litviňuková Breakdown of academic impact, for papers by Quynh Nguyen Breakdown of academic impact, for papers by Wenbin Tan Breakdown of academic impact, for papers by Jurgen Sota Breakdown of academic impact, for papers by Ying Meng Breakdown of academic impact, for papers by Xiaoming Li
Rankless by CCL
2026